| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.8M | — |
| Cost of Revenue | $1.5M | — |
| R&D Expense | $24.3M | -43.1% |
| SG&A Expense | $44.6M | +38.0% |
| Operating Income | -$73.0M | +2.6% |
| Interest Expense | $7.6M | +33.5% |
| Net Income | -$63.0M | +20.6% |
| EPS (Basic) | $0.57 | -54.0% |
| EPS (Diluted) | $0.57 | -54.0% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $46.6M | -28.0% |
| Accounts Receivable | $1.6M | — |
| Inventory | $1.9M | — |
| Current Assets | $54.5M | -18.0% |
| Total Assets | $102.2M | -18.1% |
| Current Liabilities | $25.2M | +1.3% |
| Long-term Debt | $4.2M | +0.0% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$79.1M | -12.3% |
| Capital Expenditures | $1.1M | -83.0% |
| Investing Cash Flow | -$810K | -102.4% |
| Financing Cash Flow | $61.8M | +36.8% |
| Free Cash Flow | -$80.2M | -4.5% |
| Total Liabilities |
| $105.1M |
| -20.8% |
| Stockholders' Equity | -$2.9M | +63.2% |